New features of disease after diagnosis in 6 forms of systemic vasculitis

Journal of Rheumatology

Volumn 40, Issue 11, 2013, Pages 1905-1912

  Grayson, Peter C ^a,b   Cuthbertson, David ^c   Carette, Simon ^d   Hoffman, Gary S ^e   Khalidi, Nader A ^f   Koening, Curry L ^g   Langford, Carol A ^e   Maksimowicz McKinnon, Kathleen ^h   Monach, Paul A ^a,b   Seo, Philip ⁱ   Specks, Ulrich ^j   Ytterberg, Steven R ^k   Merkel, Peter A ^k  

^a Vasculitis Center   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF UTAH   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j Mayo Clinic College of Medicine   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS; GIANT CELL ARTERITIS; GRANULOMATOSIS WITH POLYANGIITIS; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; TAKAYASU ARTERITIS; VASCULITIS

Indexed keywords

ADULT; AORTA ARCH SYNDROME; ARTHRALGIA; ARTICLE; CLAUDICATION; CONTROLLED STUDY; DISEASE DURATION; DIZZINESS; EOSINOPHILIC GRANULOMA; FEMALE; GIANT CELL ARTERITIS; GLOMERULOPATHY; GRANULOMATOSIS WITH POLYANGIITIS; HEADACHE; HEARING IMPAIRMENT; HUMAN; LUNG HEMORRHAGE; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MONONEUROPATHY; NOSE POLYP; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PURPURA; RHEUMATIC POLYMYALGIA; RHINITIS; SENSORY NEUROPATHY; SYMPTOMATOLOGY; SYSTEMIC VASCULITIS; VASCULAR DISEASE; VISUAL IMPAIRMENT; WEGENER GRANULOMATOSIS;

EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS; GIANT CELL ARTERITIS; GRANULOMATOSIS WITH POLYANGIITIS; MICROSCOPIC POLYANGIITIS; POLYARTERITIS NODOSA; TAKAYASU ARTERITIS; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SYSTEMIC VASCULITIS;

EID: 84887497270     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121473     Document Type: Article

References (41)

1. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-98.
2. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 1992;83:427-38.
3. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. Am J Med 1996;101:129-34.
4. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021-32.
5. Stone JH. Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum 2003;48:2299-309.
6. Serra A, Cameron JS, Turner DR, Hartley B, Ogg CS, Neild GH, et al. Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome. Q J Med 1984;53:181-207.
7. D'Agati V, Chander P, Nash M, Mancilla-Jimenez R. Idiopathic microscopic polyarteritis nodosa: Ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986;7:95-110.
8. Adu D, Howie AJ, Scott DG, Bacon PA, McGonigle RJ, Micheal J. Polyarteritis and the kidney. Q J Med 1987;62:221-37.
9. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30.
10. Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis Rheum 2003;49:709-15.
11. Chumbley LC, Harrison EG, Jr., DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977;52:477-84.
12. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984;63:65-81.
13. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37.
14. Keogh KA, Specks U. Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 2003;115:284-90.
15. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J, et al. Churg-Strauss syndrome: Outcome and long-term follow-up of 32 patients. Rheumatology 2001;40:763-71.
16. Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005;52:2926-35.
17. Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005;143:632-8.
18. Watts RA, Suppiah R, Merkel PA, Luqmani R. Systemic vasculitis - Is it time to reclassify? Rheumatology 2011;50:643-5.
19. WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002;23:450-68.
20. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
21. Lightfoot RW, Jr., Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
22. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
23. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
24. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
25. Tomasson G, Monach PA, Merkel PA. Thromboembolic disease in vasculitis. Curr Opin Rheumatol 2009;21:41-6.
26. Fraser JA, Weyand CM, Newman NJ, Biousse V. The treatment of giant cell arteritis. Rev Neurol Dis 2008;5:140-52.
27. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46:1309-18.
28. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A randomized trial. Ann Intern Med 2007;146:621-30.
29. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: An epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992;19:273-6.
30. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-4.
31. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
32. Fortin PR, Larson MG, Watters AK, Yeadon CA, Choquette D, Esdaile JM. Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group - A review of 45 cases. J Rheumatol 1995;22:78-84.
33. Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 2010;62:616-26.
34. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: A study in 165 patients. Br J Rheumatol 1988;27:258-64.
35. Calamia KT, Hunder GG. Clinical Manifestations of Giant-Cell (Temporal) Arteritis. Clinics in Rheumatic Diseases 1980;6:389-403.
36. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
37. Nakao K, Ikeda M, Kimata S, Niitani H, Niyahara M. Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation 1967;35:1141-55.
38. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl 1992;7:48-54.
39. Jain S, Kumari S, Ganguly NK, Sharma BK. Current status of Takayasu arteritis in India. Int J Cardiol 1996;54 Suppl:S111-6.
40. Kerr G. Takayasu's arteritis. Curr Opin Rheumatol 1994;6:32-8.
41. Faurschou M, Mellemkjaer L, Sorensen IJ, Svalgaard Thomsen B, Dreyer L, et al. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis Rheum 2009;60:1187-92. Skin Diseases and Skin Diseases